Why the study?
Pulmonary artery thrombosis in-situ occurring in the setting of Post-Acute COVID-19 syndrome is not commonly reported and remains poorly understood.
Highlights the poorly understood risk of pulmonary artery thrombosis in-situ in patients with Post-Acute COVID-19 syndrome.
Pulmonary artery thrombosis in-situ merits consideration in chest trauma or hypercoagulable states without DVT; leaves open optimal diagnostic and therapeutic approaches.
Pulmonary artery thrombosis in-situ is a term used to describe a pulmonary embolism occurs in the absence of deep vein thrombosis in the lower extremities. Most cases occur in a patient who had a recent traumatic injury to the chest. Other risk factors include the presence of hypercoagulable conditions, including inflammatory state, hypoxia and vascular endothelial injury. Although it has been discussed extensively in the acute COVID-19 disease, pulmonary artery thrombosis in-situ that occur in the setting of Post-Acute COVID-19 syndrome is not commonly reported and poorly understood.
No takes yet. Share an insight, caveat, or question.
Payus et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: